Cardiologist, Christopher Fine, MD and hematologist/oncologist Mohammed Salhab, MD discuss the management of cardiotoxicity resulting from immune checkpoint inhibitor therapy in patients with cancer.
Second Opinion - Season 7
Advertisement
In this episode of Second Opinion, Drs. Diana Isaacs and Natalie Bellini sit down to discuss the Association of Diabetes Care and Education Specialists 2022 annual meeting, which was held in Baltimore, MD, from August 12-15. The first in-person ADCES meeting since 2019, Isaacs and Bellini provide an overview of the conference, prevailing themes, and take a deep dive into their favorite sessions.
A discussion on the regulatory issues facing cannabidiol (CBD) and their sale.
Ruth Schneider and Adolfo Ramirez-Zamora join Second Opinion to discuss careers in academic medicine.
Dr. Robert Silver and Dr. Donna Raditic discuss nutraceuticals for pets covering their pros and cons, and the National Animal Supplement Council regulations. They also touch upon what further research is needed in this realm and what they see for the future of veterinary nutraceuticals.
Research Scientist Dr. Dori Beeler, of the Levine Cancer Institute of Atrium Health and corresponding author for the manuscript titled “Cancer-Related Fatigue Outcome Measures in Integrative Oncology: Evidence for Practice and Research Recommendations” that was recently published in the May issue of the journal ONCOLOGY®, was joined by co-authors Dr. Shelley Wang, of The University of Texas MD Anderson Cancer Center, and Dr. Viraj Master, of the Winship Cancer Institute of Emory University, to discuss their research. They touched on challenges in treating patients with cancer-related fatigue, such as the subjective nature of patient-reported outcome measures and the limited ability for cross-comparison across trials. In the paper, the authors compare tools for cancer-related fatigue, considerations for choosing between scales, and how to best implement them into clinical trials and daily practice. The experts provide a broad overview of their research in this episode.
The mRNA vaccines by Pfizer BioNTech and Moderna have been approved by the Centers for Disease Control for children as young as 6 months. Today, Contemporary Pediatrics talks with Carlton KK Lee, editor for The Clinical Pharmacologist’s Notebook for Contemporary Pediatrics; Residency Program Director, and associate professor, Department of Pediatrics, John Hopkins Medical Institutions, Baltimore Maryland; and Andrew J. Schuman, clinical assistant professor of pediatrics, Geisel School of Medicine at Dartmouth, Hanover New Hampshire as to who is best equipped to deliver the COVID vaccines to our littlest population.
